- Home
- NEUP vs PAVM Comparison
NEUP vs PAVM Comparison
Compare NEUP & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- PAVM
- Stock Information
- Founded
- NEUP 1996
- PAVM 2014
- Country
- NEUP United States
- PAVM United States
- Employees
- NEUP N/A
- PAVM N/A
- Industry
- NEUP
- PAVM Medical/Dental Instruments
- Sector
- NEUP
- PAVM Health Care
- Exchange
- NEUP Nasdaq
- PAVM Nasdaq
- Market Cap
- NEUP 12.7M
- PAVM 12.0M
- IPO Year
- NEUP N/A
- PAVM 2016
- Fundamental
- Price
- NEUP $7.70
- PAVM $0.59
- Analyst Decision
- NEUP Strong Buy
- PAVM Strong Buy
- Analyst Count
- NEUP 1
- PAVM 1
- Target Price
- NEUP $21.00
- PAVM $19.00
- AVG Volume (30 Days)
- NEUP 38.4K
- PAVM 119.7K
- Earning Date
- NEUP 08-15-2025
- PAVM 08-11-2025
- Dividend Yield
- NEUP N/A
- PAVM N/A
- EPS Growth
- NEUP N/A
- PAVM N/A
- EPS
- NEUP 0.00
- PAVM 0.96
- Revenue
- NEUP $15,662,715.00
- PAVM $1,993,000.00
- Revenue This Year
- NEUP N/A
- PAVM N/A
- Revenue Next Year
- NEUP N/A
- PAVM $455.63
- P/E Ratio
- NEUP $4,532.08
- PAVM $0.61
- Revenue Growth
- NEUP N/A
- PAVM N/A
- 52 Week Low
- NEUP $2.90
- PAVM $0.54
- 52 Week High
- NEUP $126.00
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- PAVM 45.37
- Support Level
- NEUP N/A
- PAVM $0.57
- Resistance Level
- NEUP N/A
- PAVM $0.62
- Average True Range (ATR)
- NEUP 0.00
- PAVM 0.03
- MACD
- NEUP 0.00
- PAVM 0.00
- Stochastic Oscillator
- NEUP 0.00
- PAVM 58.97
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.